We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
109 hedge funds and large institutions have $421M invested in Accelerate Diagnostics in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 24 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
71% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 24
70% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 10
6% more funds holding
Funds holding: 103 → 109 (+6)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
21% less capital invested
Capital invested by funds: $532M → $421M (-$111M)
75% less call options, than puts
Call options by funds: $1.21M | Put options by funds: $4.8M
Holders
109
Holders Change
+6
Holders Change %
+5.83%
% of All Funds
2.73%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.13%
New
17
Increased
41
Reduced
24
Closed
10
Calls
$1.21M
Puts
$4.8M
Net Calls
-$3.59M
Net Calls Change
-$294K
Top Buyers
| 1 |
William Blair & Company
Chicago,
Illinois
|
+$2.55M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.22M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$1.9M |
| 4 |
Morgan Stanley
New York
|
+$1.63M |
| 5 |
Credit Agricole
Montrouge Cedex,
France
|
+$1.58M |
